Navigation

BLOG ARCHIVES

Category: Cell Therapy

Raising Awareness for Rare Disease Day

By AGT | Feb 28, 2023

Contributing Author Luke Williams, Sales and Marketing  Each year on February 28th we shine a spotlight on rare disease research. There are thousands of rare diseases, and many stem from inheriting a single pathogenic gene. Traditional medicine can make patients comfortable and help ameliorate symptoms, but cannot address the root cause of disease, necessitating lifelong treatment. But exciting new innovations… [Read More]

How to Design a Gene Therapy to Target Inherited Diseases

By AGT | Feb 23, 2023

Contributing Author Luke Williams, Sales and Marketing  The human genome contains approximately 20,000 protein-coding genes. When read, these genes tell a cell how to make a specific protein, which can then be used to perform a cellular process. Variations on any of these genes can have effects ranging from eye color to lethal disorders. Conventional medicines used to treat these… [Read More]

The Biotech Project Podcast Dives into the Passionate Vision of Jeff Galvin

The Biotech Project Podcast Dives into the Passionate Vision of Jeff Galvin

By AGT | Jan 19, 2023

The Biotech Project podcast hosts Scott J Resnik, MBA, NYS EMT-CC, and John Walsh, MD, sit down with American Gene Technologies® founder and CEO Jeff Galvin for a lively and inspiring discussion.Watch the full episode to follow Jeff’s journey as he builds a company that’s on a path toward revolutionizing the traditional approach to treating diseases by daring to aim… [Read More]

American Gene Technologies Celebrates Another Year of Progress

By AGT | Dec 28, 2022

Contributing Author John Vandermosten, Senior Biotechnology Analyst In 2022, the world was collectively compelled to endure a surge in viral outbreaks, the horror of the Russia-Ukraine war and rampant inflation, which has led many to a state of pessimism. But, the dramatic events of 2022 have overshadowed other, more reassuring news. In contrast to the gloom of this daily news cycle,… [Read More]

AGT Phase 1 HIV Clinical Trial Data Published in Frontiers in Medicine

Phase 1 HIV Clinical Trial Data Published in “Frontiers in Medicine” Journal

By AGT | Dec 22, 2022

Contributing Author Luke Williams, Sales and Marketing  American Gene Technologies® (AGT) designed AGT103-T in hopes of functionally curing HIV. The therapeutic is made of the patient’s own T cells which have been enhanced for HIV resistance, and data from the Phase 1 human trial has recently been published in the journal Frontiers in Medicine. HIV is a curable condition, as… [Read More]

Gene Therapy Clinical Trial Requirements

By AGT | Dec 7, 2022

Contributing Author John Vandermosten, Senior Biotechnology Analyst Gene Therapy Does It “My Way” In 1990, gene therapy burst onto the world stage with the first clinical trial aimed at a genetic disease.  This effort, led by a team at the National Institute of Health, successfully treated a four-year-old girl with severe combined immunodeficiency (SCID), more commonly known as bubble boy disease…. [Read More]

ShareTreck Interviews Jeff Galvin on the Future of Medicine

ShareTreck Host Interviews Jeff Galvin on The Future of Medicine

By AGT | Nov 28, 2022

Raj Natarajan, host of ShareTreck, goes behind the scenes with Jeff Galvin, Founder and CEO of American Gene™ in this compelling interview learn how gene therapy works, and what it means for people with deadly diseases, as well as how it will impact the current pharmaceutical landscape. The company is currently in the midst of a human clinical trial using… [Read More]

Top Cell Therapy Approvals and Pipeline / Cell Therapy is More Than CAR T

Top Cell Therapy Approvals and Pipeline / Cell Therapy is More Than CAR T

By AGT | Oct 18, 2021

Contributing Author John Vandermosten, Senior Biotechnology Analyst Cell therapy is the transfer of therapeutic cells to a patient.  It replaces damaged cells or enhances normal cells with modified new ones.[1]  The cells used in the process may be autologous or allogeneic; however, they must be recognized by the immune system in a way that will promote the desired response.  Some cell… [Read More]

What Is CAR T-Cell Therapy? How It Works In 2-Minutes

What Is CAR T-Cell Therapy? How It Works In 2-Minutes

By AGT | May 13, 2021

Contributing Author : Gina  Big Picture  Cancer is a leading cause of death worldwide. In the U.S., only heart disease ranks above it. The American Cancer Society estimates that in the U.S. in 2021, there will be nearly 2 million new cancer cases and more than 600,000 cancer deaths from all types of cancer combined. However, our individual immune systems… [Read More]

What is Stem Cell Therapy

What Is Stem Cell Therapy? How It Works In 2-Minutes

By AGT | Apr 23, 2021

Contributing Author : Gina Big Picture    Genomic medicine is bringing hope where none previously existed. This approach to cure and treat human diseases uses human biology rather than chemical compounds made in the lab to unlock techniques and therapies with the power to cure formerly incurable diseases. The use of gene therapy, CAR T cell therapy, stem cell, and… [Read More]

7 Cell Therapy Companies in Maryland Helping to Revolutionize Drug Discovery: The Latest News

By AGT | Dec 29, 2020

Contributing Author: Gina Hagler Maryland is home to one of the largest life science clusters in the United States with more than 500 biotech companies. In addition to several state-of-the-art labs, Maryland is home to the NIH in Bethesda. Research opportunities, as well as BS and MS degree programs, are offered at Johns Hopkins in Baltimore and the University of Maryland… [Read More]

Cell Therapy Development is Creating the Next Generation Cures for Cancers

Cell Therapy is Creating the Next Generation Cures for Cancers

By AGT | Dec 22, 2019

Today Human immunity is a beautifully complex system. Students of science around the world groan at the mention of immunology because of its never-ending overlapping cell types and pathways. Those groans are being replaced with genuine interest as immuno-oncology becomes a reality. Excitement exploded in 2017 when two cancer treatments that modify immune cells (CAR-T) were approved by the U.S…. [Read More]

Subscribe to Our Newsletter

Subscribe to our newsletter to keep up to date with all the latest news about AGT!

Mailchimp sidebar

Follow AGT on Social Media